1 / 6

FP7 Experience (Collaborative Project Application)

FP7 Experience (Collaborative Project Application). Matthew D. Griffin. MB BCh , DMed Professor of Transplant Biology Regenerative Medicine Institute (REMEDI) NUI Galway, Ireland. Summary. D escription of application. What could have made a difference? Positive aspects.

desma
Download Presentation

FP7 Experience (Collaborative Project Application)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FP7 Experience(Collaborative Project Application) Matthew D. Griffin. MB BCh,DMed Professor of Transplant Biology Regenerative Medicine Institute (REMEDI) NUI Galway, Ireland

  2. Summary • Description of application. • What could have made a difference? • Positive aspects.

  3. FP7-Health-2013.1.3-2: Innovative approaches to address adverse immune reactions to biomedical devices, implants and transplant tissues STAGE 1 June 2012: Reviewed draft call and drew up initial concept and partner profiles. Discussed possible academic and industry partners with colleagues. Reviewed successful applications. July 2012: Began sending initial communications to potential partners – Ireland, UK, France, Denmark, Germany. Identified management company to work with. Applied for EI Coordinator Support (€12,000) August 2012: 11 partners identified. Began to draft Stage 1 application and initial budget. October 2012: Submitted Stage 1 application. December 2012: Decision on Stage 1 (Deadline Feb. 2nd 2013)

  4. Stage 2: Dec 2012- Feb 2013 (nine weeks) Large time commitment: • Writing/Editing • Almost daily contact with Management Company. • E mail/conference calls/face-to-face meetings with partners • Budget development (needed help) • Submitted evening before deadline (Feb 5th 2013). Outcome: • Received decision e mail April 23rd 2013: “passed thresholds” for funding but placed on reserve list based on overall ranking. • Marks: • S&T Excellence 4/5. • Implementation and Management 4/5. • Potential Impact 4/5.

  5. What could have made a difference? Feedback (weaknesses) • Translation to other types of transplant. (not fixable) • Statistical power analysis for clinical study. (fixable) • Management of project complexity. (fixable) On Reflection • Should have engaged with a biostatistician at Stage 1. • Should have paid more attention to critically evaluating the management plan. • Time restriction played a role.

  6. Positive Aspects • Appreciate that NUI Galway is well resourced to coordinate EU collaborative projects. • Understand EU funding system and process of preparing and submitting applications. • Understand process of engaging with partners. • Improved grant preparation skills – writing for impact. • New connections in academia and industry. • New scientific ideas and project concepts. • Much better prepared to re-engage – but essential that the project fits the call.

More Related